CTOs on the Move

Nursefinders of Indianapolis

www.nfindy.com

 
Nursefinders of Indianapolis is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nfindy.com
  • 8925 N Meridian St Ste 100
    Indianapolis, IN USA 46260
  • Phone: 317.818.4400

Executives

Name Title Contact Details

Similar Companies

Excerpta Medica

Excerpta Medica is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Haven Health

Haven Health Group is a group of individual long term care facilities based throughout Arizona that provide skilled nursing, rehabilitation, respite, hospice, physical, occupational, and speech therapy, and long term care services.

Secret Harbor

Secret Harbor is a Burlington, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beth Israel Lahey Health

Beth Israel Lahey Health is a new, integrated system providing patients with better care wherever they are. Care informed by world-class research and education. We are doctors and nurses, technicians and social workers, innovators and educators, and so many others. All with a shared vision for what health care can and should be.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.